Apolipoprotein E: Diversity of Cellular Origins, Structural and Biophysical Properties, and Effects in Alzheimer's Disease
Abstract
Apolipoprotein E4 (apoE4) is a major risk factor for Alzheimer's disease (AD). Several hypotheses have been proposed to explain the association of the APOE epsilon4 allele with AD; however, the mechanisms underlying this association are largely unknown. Initially, apoE was thought to be synthesized primarily by astrocytes but not by neurons in the brain. However, subsequent studies have demonstrated that central nervous system neurons also express apoE under diverse physiological and pathological conditions. Detailed studies of the structure and biophysical properties of apoE isoforms have demonstrated unique properties distinguishing apoE4 from apoE3. Because the structural and biophysical properties of a protein determine how it functions under normal and abnormal conditions, apoE4, with its multiple cellular origins and multiple structural and biophysical properties, might contribute to the pathology of AD through several different mechanisms. Some of these mechanisms might be suitable targets for the development of new treatments for AD.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the brain, apoE is produced mainly by astrocytes, although microglia and neurons can synthesize apoE under various physiological and pathological conditions.
“In the brain, apoE is mainly produced by astrocytes, although microglia and neurons can synthesize apoE under various physiological and pathological conditions [66,67].”
From Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: A review (2016) · cites this paper as [66]
In the brain, apoE is mainly produced by astrocytes, although microglia and neurons can synthesize apoE under various physiological and pathological conditions.
“In the brain, apoE is mainly produced by astrocytes, although microglia and neurons can synthesize apoE under various physiological and pathological conditions [66,67].”
From Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: A review (2016) · cites this paper as [66]
Cellular origin plays a crucial role in apoE's biophysical properties and pathological effects.
“Cellular origin plays a crucial role in apoE’s biophysical properties and pathological effects.”
From Apolipoprotein E4, inhibitory network dysfunction, and Alzheimer’s disease (2019) · cites this paper as [28]
The citation lists haven’t been fetched yet
References 158 · Cited by 242
- Authors
- Huang, Y., Weisgraber, K. H., Mucke, L., & Mahley, R. W.
- Affiliations
- University of California, San Francisco (US)
- Corresponding author
- Huang, Yadong
- Venue
- Journal of Molecular Neuroscience
- Published
- 2004
- Volume
- 23
- Issue
- 3
- Pages
- 189-204
- ISSN
- 0895-8696 (ISSN-L)
- OpenAlex
- W1964203272
- Cited by
- 242
- References
- 158
- Citations by year
- 2026: 11 · 2025: 17 · 2024: 8 · 2023: 14 · 2022: 10 · 2021: 8 · 2020: 9 · 2019: 11 · 2018: 5 · 2017: 7 · 2016: 7 · 2015: 9 · 2014: 11 · 2013: 14 · 2012: 11
- FWCI
- 8.86
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Molecular Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5p01hl047660-10, 1r01ns045212-01)
- National Institute on Aging (AG-20235, AG-11385, AG022074, R01AG020235, P01AG022074)
- National Heart, Lung, and Blood Institute (HL64162, HL 37063, R01HL064162, HL-47660, R01HL037063)
- National Institute of Neurological Disorders and Stroke (NS046465, R21NS046465, NS045212)
- Topics
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- apolipoprotein E, APOE ε4, Alzheimer's disease, APOE isoforms, APOE3, astrocytes, disease mechanisms, therapeutic target
- MeSH terms
- Alzheimer Disease, Apolipoproteins E, Astrocytes, Brain, Humans, Models, Molecular, Neurons, Protein Conformation, Genetic Variation, Apolipoprotein E4
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review